Dr Bozena Michniak-Kohn, director of the Laboratory for Drug Delivery at Rutgers, reports improvement of the NextACT technology used in the delivery of an important drug for treating nausea and vomiting. Ondansetron is administered to counter these side effects following surgery and during chemotherapy.

Ondansetron is administered to counter these side effects following surgery and during chemotherapy. Dr Michniak-Kohn’s research, conducted at the New Jersey Center for Biomaterials, found a way to significantly improve the permeation of ondansetron by delivering the drug through oral tissue. Her data and findings were published in the November 5th issue of International Journal of Pharmaceutics in the article, “Enhanced in vitro Transbuccal Drug Delivery of Ondansetron HCI”.

Please click here to view the announcement from Apricus Biosciences. Dr Michniak-Kohn is a faculty member of the Ernest Mario School of Pharmacy at Rutgers, the State University.